Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer

European Journal of Surgical Oncology

Volumn 32, Issue 10, 2006, Pages 1226-1230

  Behtash, N ^a   Nazari, Z ^b   Ayatollahi, H ^c   Modarres, M ^a   Ghaemmaghami, F ^a   Mousavi, A ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cervical carcinoma; Concomitant chemoradiation; Neoadjuvant chemotherapy; Radical hysterectomy

Indexed keywords

CISPLATIN; VINCRISTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; RECURRENCE RISK; RISK FACTOR; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; VINCRISTINE;

EID: 33751182118     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.07.012     Document Type: Article

References (32)

1. Mohar A., and Frias-Mendivil M. Epidemiology of cervical cancer. Cancer Invest 18 (2000) 584-590
2. Delgado G., bundy B., and Zaino R. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix, a Gynecologic Oncology Group Study. Gynecol Oncol 38 (1990) 352-357
3. Ballon S., Berman M., Lagasse L., Pertrilli E., and Castaldo T. Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet Gynecol 57 (1981) 90-95
4. Gauthier P., Gore I., Shingleton H.M., Soong S.J., Orr J.W., and Hatch K.D. Identification of histopathologic risk group in stage IB squamous cell carcinoma of the cervix. Obstet Gynecol 66 (1985) 569-573
5. Lai C.H., Hsueh S., Chang T.C., et al. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 64 (1997) 456-462
6. Chang H.C., Lai C.H., Chou P.C., et al. Neoadjuvant chemotherapy with Cisplatin, Vincristine, and Bleomycin and radical surgery in early-stage bulky cervical carcinoma. Cancer Chemother Pharmacol 30 (1992) 281-285
7. Friedlander M., Kaye S.B., Sullivan A., et al. Cervical carcinoma: a drug responsive tumor experience with combined Cisplatin, Vinblastine, Bleomycin. Gynecol Oncol 16 (1983) 275-281
8. Kim D.S., Moon H., Hwang Y.Y., and Cho S.H. Preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib, IIa, and IIb with bulky tumor. Gynecol Oncol 29 (1988) 321-332
9. Weiner S.A., Aristzabal S., Alberts D.S., Surwitt E.A., and Deatherage-Deuser K. A phase II trial of Mitomycin, Vincristine, Bleomycin, and Cisplatin (MOBP) as neoadjuvant therapy in high risk cervical carcinoma. Obstet Gynecol 30 (1988) 1-6
10. Panici P.B., Scambia G., Baiocchi G., et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Prognostic factors for response and survival. Cancer 67 (1991) 372-379
11. Zanetta G., Lissoni A., Gabriele A., et al. Intense neoadjuvant chemotherapy with Cisplatin and Epirubicin for advanced or bulky cervical and vaginal adenocarcinoma. Gynecol Oncol 64 (1997) 431-435
12. Benedetti-Panici P., Maneschi F., Cutillo G., et al. Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical results. Cancer 78 (1996) 2359-2365
13. Iwasaka T., Fukuda K., Hara K., et al. Neoadjuvant chemotherapy with mitomycin C, etoposide, and cisplatin for adenocarcinoma of the cervix. Gynecol Oncol 70 (1998) 236-240
14. Sardi J.E., Giaroli A., Sananes C., et al. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: the final results. Gynecol Oncol 67 (1997) 61-69
15. deSouza N.M., Soutter W.P., Rustin G., et al. Use of neoadjuvant chemotherapy prior to radical hysterectomy in cervical cancer: monitoring tumor shrinkage and molecular profile on magnetic resonance and assessment of 3-year outcome. Br J Cancer 90 (2004) 2326-2331
16. Hacker N.F. Cervical cancer. In: Berek J.S., and Hacker N.F. (Eds). Practical gynecologic oncology. Fourth edition (2005), Lippincott Williams and Wilkins, Philadelphia 337-395
17. Piver M.A., and Chung W.S. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 46 (1975) 507-510
18. Harris D.T. Introduction: adjuvant and neoadjuvant therapy. Semin Oncol 22 (1995) 529
19. Minagawa Y., Kigawa J., Irie T., Okada M., Kanamori Y., and Terakawa N. Radical surgery following neoadjuvant chemotherapy for patients with stage IIIb cervical cancer. Ann Surg Oncol 5 (1998) 539-543
20. Kigawa J., Minagawa Y., Ishihara H., Itamochi H., Kanamori Y., and Terakawa N. The role of neoadjuvant chemotherapy intra-arterial infusion chemotherapy with Cisplatin and Bleomycin for locally advanced cervical cancer. Am J Clin Oncol 19 (1996) 255-259
21. Forastiere A.A., Urba S.G., and Liggett W. Neoadjuvant therapy. Cancer J Sci Am 2 (1996) 126
22. Peters III W.A., Liu P.Y., Barrett II R.J., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1613
23. Hwang Y.Y., Moon H., Cho S.H., et al. Ten-year survival of patients with locally advanced stage IB-IIB cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Gynecol Oncol 82 (2001) 88-93
24. Edelmann D.Z., and Anteby S.O. Neoadjuvant chemotherapy for locally advanced cervical cancer-where does it stand? A review. Obstet Gynecol Surv 51 (1996) 305-313
25. Panici P.B., Scambia G., Baiocchi G., et al. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 67 (1991) 372-379
26. Eddy G.L., Manetta A., Alvarez R.D., Williams A., and Creasman W.T. Neoadjuvant chemotherapy with Vincristin and Cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a gynecologic oncology group pilot study. Gynecol Oncol 57 (1995) 412-416
27. Kim S.M., Choi H.S., and Byun J.S. Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection. Int J Gynecol Cancer 10 (2000) 305-312
28. Yuan C.C., Wang P.H., Lai C.R., Tsu E.J., Yen M.S., and Ng H.T. Recurrence and survival analyses of 1,115 cervical cancer patients treated with radical hysterectomy. Gynecol Obstet Invest 47 (1999) 127-132
29. Frigerio L., Mariani A., Gandini L., et al. Prognostic factors in patients with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy. Int Surg 83 (1998) 265-270
30. Duenas-Gonzalez A., Lopez-Graniel C., Gonzalez-Enciso A., et al. A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation. Ann Oncol 14 (2003) 1278-1284
31. Chang T.C., Lai C.H., Hong J.H., et al. Randomized trial of neoadjuvant cisplatin, vincristine, bleomycin, and radical hysterectomy versus radiation therapy for bulky stage IB and IIA cervical cancer. J Clin Oncol 18 (2000) 1740-1747
32. Grigsby P.W. Primary radiotherapy for stage IB or IIA cervical cancer. J Natl Cancer Inst Monogr 21 (1996) 61-64